Literature DB >> 27708956

Therapy resistant idiopathic scleredema: an underlying pathology not always present.

Melike Kalfa1, Hayriye Koçanaoğulları1, Figen Yargucu Zihni1, Gonca Karabulut1, Hakan Emmungil1, Vedat İnal1.   

Abstract

Scleredema is a rare connective tissue disorder of unknown pathogenesis. Three types of scleredema have been described, based on its association with postinfection, monoclonal gammopathy and diabetes mellitus. We report herein a case of scleredema which the diagnosis didn't get specified. The patient was followed regularly for 13 years and did not respond to various combinations of immunosuppressants and psoralen plus ultraviolet A therapy. Treatment of scleredema is quite difficult and of limited success. At present, there is no proved treatment for this disease.

Entities:  

Keywords:  PUVA; Scleredema; methotrexate

Year:  2015        PMID: 27708956      PMCID: PMC5047231          DOI: 10.5152/eurjrheum.2015.0004

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  10 in total

1.  Scleredema of Buschke successfully treated with electron beam therapy.

Authors:  L M Tamburin; J R Pena; R Meredith; V Y Soong
Journal:  Arch Dermatol       Date:  1998-04

Review 2.  Localized cutaneous fibrosing disorders.

Authors:  Aaliya Yaqub; Lorinda Chung; Kerri E Rieger; David F Fiorentino
Journal:  Rheum Dis Clin North Am       Date:  2013-03-16       Impact factor: 2.670

Review 3.  Scleroderma mimics.

Authors:  Jennifer Nashel; Virginia Steen
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

4.  Scleredema associated with paraproteinaemia treated by extracorporeal photopheresis.

Authors:  G I Stables; P C Taylor; A S Highet
Journal:  Br J Dermatol       Date:  2000-04       Impact factor: 9.302

Review 5.  Scleredema adultorum of Buschke: a case report and review of the literature.

Authors:  William H Beers; Akgun Ince; Terry L Moore
Journal:  Semin Arthritis Rheum       Date:  2006-06       Impact factor: 5.532

6.  Scleredema adultorum.

Authors:  R C Parmar; S B Bavdekar; S Bansal; A Doraiswamy; S Khambadkone
Journal:  J Postgrad Med       Date:  2000 Apr-Jun       Impact factor: 1.476

Review 7.  Electron-beam therapy in scleredema adultorum with associated monoclonal hypergammaglobulinaemia.

Authors:  C Angeli-Besson; M C Koeppel; P Jacquet; L Andrac; J Sayag
Journal:  Br J Dermatol       Date:  1994-03       Impact factor: 9.302

8.  Scleredema: a review of thirty-three cases.

Authors:  P Y Venencie; F C Powell; W P Su; H O Perry
Journal:  J Am Acad Dermatol       Date:  1984-07       Impact factor: 11.527

Review 9.  Scleredema adultorum of Buschke treated with radiation.

Authors:  Anneli R Bowen; Lynn Smith; John J Zone
Journal:  Arch Dermatol       Date:  2003-06

Review 10.  From scleredema to AL amyloidosis: disease progression or coincidence? Review of the literature.

Authors:  Magdalena Dziadzio; Constantinos P Anastassiades; Philip N Hawkins; Michael Potter; Armando Gabrielli; Geraldine M Brough; Carol M Black; Christopher P Denton
Journal:  Clin Rheumatol       Date:  2005-03-02       Impact factor: 2.980

  10 in total
  1 in total

1.  Screening for the presence of scleroedema adultorum of Buschke in patients with diabetes mellitus: newly diagnosed patients had a high prevalence of dyslipidaemia.

Authors:  Viktória Csonka; Beáta Bódis; Dániel Kovács; Nelli Farkas; Endre Kálmán; László Czirják; Cecília Varjú
Journal:  Lipids Health Dis       Date:  2021-05-05       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.